EVEREST ORGANICS LTD. Share Price

Everest Organics Limited is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and intermediaries. It is involved in the manufacturing of bulk drugs. The Company’s API products include Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate, Esomeprazole Magnesium Dihydrate, Esomeprazole Sodium, Omeprazole Sodium, Omeprazole Magnesium, Fenofibrate, Tamsulosin Hcl, and Dexlansoprazole. Its products under development include Remdesivir, Molnupiravir, Carbidopa, Acotiamide HCL, and Apixaban. Its intermediates products include Ethyl 2-(4-Hydroxyphenyl)-4-Methyl-5-Thiazolecarboxylate, Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5- Carboxylate, Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate, Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate, 2-Chloromethyl-4-Methoxy-3-Methyl-Pyridine Hydrochloride, and 5-(1H-Pyroll-1-yl)-2-Mercaptobenzimidazole, among others.As of 9 Jun 2026, EVEREST ORGANICS LTD. share price is ₹240.00. The stock opened at ₹250.15, compared to its previous close of ₹250.10. During today's trading session, EVEREST ORGANICS LTD. share price moved in the range of ₹240.00 to ₹250.15, with an average price of ₹245.07 for the day. Looking at its last 52-week, the stock has touched a low of ₹240.00 and a high of ₹250.15.

The market capitalization of EVEREST ORGANICS LTD. is ₹243 Crs, with a P/E ratio of 43.8 and a dividend yield of 0.00%.